| ABVD | doxorubicin–bleomycin–vinblastine–dacarbazine |
| AUC | area under the receiver operating characteristic curve |
| CALLY | C-reactive protein–albumin–lymphocyte |
| CI | confidence interval |
| CRP | C-reactive protein |
| ESR | erythrocyte sedimentation rate |
| 18F-FDG | 18F-fluorodeoxyglucose |
| HR | hazard ratio |
| IPS | International Prognostic Score |
| IQR | interquartile range |
| LMR | lymphocyte-to-monocyte ratio |
| NLR | neutrophil-to-lymphocyte ratio |
| OR | odds ratio |
| OS | overall survival |
| PET/CT | positron emission tomography/computed tomography |
| PFS | progression-free survival |
| PLR | platelet-to-lymphocyte ratio |